Details

NameSymbolSector
LINCOLN PHARMACEUTICALS LTD.LINCOLNPharmaceuticals
Open
638
High
644.4
Low
609.3
Close
613.4
Volume
134766
Exchange
nse
Time
14-Aug-2026

Outlook

Score:

2.75

Rating:

RISKY

Candlestick Pattern

CandlepatternofLincolnPharmaceuticalsis
Long Body
EstimatedStoplossofLincolnPharmaceuticalsis
644.4
LincolnPharmaceuticalshasa
Bearishℹ
pattern.
Formationof
Long Body
candlepatternindicatesthetrenddirectionofLincolnPharmaceuticalsmaybe
Unpredictableℹ
,butkeepalookoutforfallinprice.

Trend

LincolnPharmaceuticalsisin
Sideways trendℹ
.
PriceofLincolnPharmaceuticalsis
Upℹ
by

0.65

%.
Target
Buy@

538.19

Sell@

718.83

Current@

613.4

Volume

ThetradesofLincolnPharmaceuticalshavebeenin
Immenseℹ
volume.
ThevolumetradesforLincolnPharmaceuticalsare
Bullishℹ
with
Strong Buyersℹ
ThetradevolumeofLincolnPharmaceuticalsis

Up

by

77.69

%

Valuation

ThecurrentmarketpriceofLincolnPharmaceuticalsis
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth797crandtotalassetsworth797cr,thebalancesheetofLincolnPharmaceuticalsis:
Balancedℹ
.
Cashflow
LincolnPharmaceuticalshas
Sufficientℹ
cashflowbecausethereis

Surplus

of

₹ 7cr

.Itis
Upℹ
by

0

%.
52.54% i.e. ₹ 93cr earned in operatingℹ
44.07% i.e. ₹ 78cr spent in investingℹ
3.39% i.e. ₹ 6cr spent in financingℹ
0% in otherℹ
LincolnPharmaceuticalshas
Insufficientℹ
cashflowbecauseitis

₹ 0cr

.Itis
Upℹ
by

100

%.
50.4% i.e. ₹ 63cr earned in operatingℹ
45.6% i.e. ₹ 57cr spent in investingℹ
4% i.e. ₹ 5cr spent in financingℹ
0% in otherℹ
Income
TheincomeofLincolnPharmaceuticalsis

₹ 170cr

and

Profit

is:

₹ 19cr

LincolnPharmaceuticalsProfitisdownby:

29.63

%andIncomeisUpby:

0.59

%
TheincomeofLincolnPharmaceuticalsis

₹ 169cr

and

Profit

is:

₹ 27cr

LincolnPharmaceuticalsProfitisupby:

145.45

%andIncomeisUpby:

4.97

%
TheincomeofLincolnPharmaceuticalsis

₹ 161cr

and

Profit

is:

₹ 11cr

LincolnPharmaceuticalsProfitisdownby:

45

%andIncomeisUpby:

3.87

%
By using this site you agree to the use of cookies to deliver a better site experience.